로딩 중…
지수 로딩 중…
SAMJIN PHARMACEUTICAL CO.,LTD
005500· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩18,910+0.53%
2026-06-19
Price Chart
SAMJIN PHARMACEUTICAL CO.,LTD-1.72%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 251.88B KRW |
| Revenue | 306.35B KRW |
| Net Income | 6.60B KRW |
| Total Assets | 452.49B KRW |
| Net Assets | 277.59B KRW |
| Employees | 809 |
| Value | |
| P/E | 38.14x |
| P/B | 0.91x |
| P/S | 0.82x |
| EV/EBITDA | 122.47x |
| FCF Yield | 8.92% |
| Profitability | |
| ROE | 2.38% |
| ROA | 1.46% |
| Op. Margin | 0.97% |
| Revenue Growth | -3.93% |
| Earnings Growth | -62.56% |
| Financial Health | |
| Debt Ratio | 63.00% |
| Total Debt | 119.00B KRW |
| FCF | 22.47B KRW |
| Cash | 7.14B KRW |
| Current Ratio | 1.28x |
| Net Debt/EBITDA | 37.66x |
| Dividend | |
| Div. Yield | 4.25% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -1.72% |
| 1M Return | -12.45% |
| From 52W High | -26.99% |
| 1Y MDD | -24.33% |
| Trading | |
| Volume | 68,979 shares |
| Foreign Own. | 3.46% |
| Per Share | |
| EPS | 1,594 KRW |
| BPS | 21,931 KRW |
Company Info
Samjin Pharmaceutical, established in 1968, manufactures and sells pharmaceuticals, boasting a diverse portfolio that includes Gabol tablets and Plaless tablets. The company is expanding its business into health functional foods, cosmetics, and medical devices, with a strong focus on developing new drugs for conditions such as cancer and dementia. Following the completion of an EU-GMP-grade injectable line at its Osong raw material synthesis plant in 2022, Samjin Pharmaceutical is boosting production and facility investments for global growth. Samjin Pharmaceutical is headquartered in Mapo-gu, Seoul.